Market Place
Sourcing Support
Curium Opens New Netherlands Facility for Lutetium-177
24 Sep 2024 //
GLOBENEWSWIRE
Curium Submits New Drug Application for Lutetium Lu 177 Dotatate Injection
09 Jul 2024 //
GLOBENEWSWIRE
Curium: Adds ILL Reactor For Lu-177 Supply Over 5 Years
05 Jun 2024 //
GLOBENEWSWIRE
Supply constraints force pause of BMS, RayzeBio trial enrollment
04 Jun 2024 //
FIERCE PHARMA
Curium Extends Lutetium-177 Supply Deal With NRG I PALLAS
29 May 2024 //
GLOBENEWSWIRE
ITM Announces Operational Readiness for NOVA Facility
04 Jan 2024 //
GLOBENEWSWIRE
Vancouver Earns Therapeutic License to Administer New Drug to Treat Cancer
08 Mar 2023 //
PR NEWSWIRE
Philochem AG, Seibersdorf Labor GmbH and Isotopia announce agreements
13 Dec 2022 //
PRNEWSWIRE
Isotope Production System Begins Production of Cancer-Fighting Lutetium-177
24 Oct 2022 //
GLOBENEWSWIRE
Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement
21 Sep 2022 //
BUSINESSWIRE
SHINE Technologies Submits DMF to FDA for Non-Carrier-Added Lu-177 Chloride
29 Jul 2022 //
PRNEWSWIRE
MTTI and ITM Sign Clinical Supply Agreement for n.c.a. Lutetium-177
13 Apr 2022 //
BUSINESSWIRE
ITM Provides Lutetium-177 as Long-Term Supplier for Recently Approved Pluvicto
23 Mar 2022 //
PRESS RELEASE
Telix Expands Lutetium-177 Network with Eckert & Ziegler Supply Agreement
08 Feb 2022 //
GLOBENEWSWIRE
Novartis prostate cancer drug receives US FDA breakthrough designation
18 Jun 2021 //
REUTERS
Clovis Oncology seeks US FDA nod to initiate ph 1/2 study lutetium-177 FAP-2286
31 Dec 2020 //
PHARMABIZ
Agreement Signed to Advance Lutetium-177 Isotope Production to Meet Global
30 Oct 2020 //
BUSINESSWIRE
Radiopharmaceutical cancer treatment Lutathera® now available
08 Oct 2020 //
BUSINESS INSIDER
Novartis plots 2nd US factory to meet demand for Lutathera cancer radiotherapies
02 Jul 2020 //
FIERCE PHARMA
ITM and POINT Biopharma Sign Two Supply Agreements for Lutetium-177
23 Jun 2020 //
BUSINESSWIRE
New preclinical Data Offer Insights Into Enhancing Betalutin
03 Dec 2019 //
PR NEWSWIRE
Nordic Nanovector, Isotope Technologies Enter Supply Pact
08 Oct 2019 //
CONTRACT PHARMA
Zolgensma launch `on track and fully in line` with expectation, says CEO
19 Jul 2019 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.